# Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors

> **NCT06821048** · PHASE1 · RECRUITING · sponsor: **Weijia Fang, MD** · enrollment: 18 (estimated)

## Conditions studied

- Colorectal Cancer
- Stomach Cancer
- Pancreatic Cancer
- Metastatic Cancer

## Interventions

- **BIOLOGICAL:** Intraperitoneal infusion of FAST CEA-targeted CAR-T

## Key facts

- **NCT ID:** NCT06821048
- **Lead sponsor:** Weijia Fang, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-24
- **Primary completion:** 2026-06-01
- **Final completion:** 2027-12-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2026-01-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06821048

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06821048, "Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors". Retrieved via MORVS 2026-10-10 from https://api.morvs.ai/clinical/NCT06821048. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*